50 results on '"Miller, Fiona A."'
Search Results
2. 1.65 Health Risk Behaviors Among Youth Admitted to a Psychiatric Hospital: Comparisons to a Population-Based Community Sample
3. 1.66 Rates of Self-Reported Childhood Trauma in Youth Who Are Psychiatrically Hospitalized: Comparisons to a Population-Based Representative Community Sample
4. Multidisciplinary perspectives on the regulation of diagnostic technologies
5. Double displacement – Interactions between resettlement, environmental change and migration
6. Comparison of outpatient coverage in Canada: Assistive and medical devices
7. Defining the decision problem: A scoping review of economic evaluations for Clostridioides difficile interventions
8. Mitigating Health Care's Contribution to the Climate Crisis
9. Industry, experts and the role of the ‘invisible college’ in the dissemination of non-invasive prenatal testing in the US
10. Outcomes of Lower Limb Angioplasty Vary by Area Deprivation in England
11. The Federal Spending Power: Building Forward after the Pandemic
12. Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regime
13. The innovation impacts of public procurement offices: The case of healthcare procurement
14. The Consultant's intermediary role in the regulation of molecular diagnostics in the US
15. Rebalancing health systems toward community-based care: The role of subsectoral politics
16. Quantifying the Effects of 16p11.2 Copy Number Variants on Brain Structure: A Multisite Genetic-First Study
17. Expanding the clinical role of community pharmacy: A qualitative ethnographic study of medication reviews in Ontario, Canada
18. SPARK: A US Cohort of 50,000 Families to Accelerate Autism Research
19. Opportunities for Engaging Canadian Health Systems in Addressing the Challenge of Climate Change
20. Controversy and debate on clinical genomics sequencing—paper 3: response to “clinical genome-wide sequencing: do not throw out the baby with the bathwater”
21. Controversy and debate on clinical genomics sequencing—paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing
22. Managing sickle cell carrier results generated through newborn screening in Ontario: a precedent-setting policy story
23. Psychosocial Response to Uncertain Newborn Screening Results for Cystic Fibrosis
24. A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis
25. Organizing the entrepreneurial hospital: Hybridizing the logics of healthcare and innovation
26. Valuing technology: A qualitative interview study with physicians about insulin pump therapy for children with type 1 diabetes
27. Addressing Patient Needs and Public Commitments in Health Technology Innovation: A Review of Patient and Public Engagement in Technology Development and Assessment
28. The Cognitive and Behavioral Phenotype of the 16p11.2 Deletion in a Clinically Ascertained Population
29. BT's adoption of customer centric design
30. Parents’ Willingness to Pay for Biologic Treatments in Juvenile Idiopathic Arthritis
31. In the loop: Primary care providers' role in newborn screening for cystic fibrosis
32. How does learning false positive results through newborn screening for cystic fibrosis influence cascade testing and family planning?
33. Patient- and family-oriented outcomes for inborn errors of metabolism: A scoping review
34. Patient- and family-oriented outcomes for inborn errors of metabolism: The perspective of patient advocacy and support groups
35. Building a pan-Canadian practice-based research network for inherited metabolic diseases: The first two years of the Canadian Inherited Metabolic Diseases Research Network (CIMDRN)
36. The epidemiology and health service impact of medium-chain acyl-CoA dehydrogenase deficiency among affected children and those with false positive newborn screening results in Ontario
37. Making sense of diagnostic uncertainty after newborn screening for cystic fibrosis
38. Horizon 2020 and the need to reinvent health technology development
39. Leveraging the “living laboratory”: On the emergence of the entrepreneurial hospital
40. Subintimal angioplasty for femoro-popliteal occlusive disease
41. Ethics and Newborn Genetic Screening: New Technologies, New Challenges
42. Factor V Leiden Mutation and Antiphospholipid Syndrome: Risk Factors for Atherosclerotic and Arterial Thromboembolic Disease
43. What does it mean to trust a health system?
44. Imagining value, imagining users: Academic technology transfer for health innovation
45. Contending visions in the evolution of genetic medicine: The case of cancer genetic services in Ontario, Canada
46. High definition three-dimensional ultrasound to localise the tumour bed: A breast radiotherapy planning study
47. ‘Your true and proper gender’: the Barr body as a good enough science of sex
48. Understanding the new human genetics: A review of scientific editorials
49. Ruling in and ruling out: Implications of molecular genetic diagnoses for disease classification
50. The effectiveness of intermediate care in a nursing-led in-patient unit
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.